Delivery Order SPE2DB20D3101-SPE2DB23FRYE3

Award Date 9/19/23
Potential Completion Date 9/20/23
Potential Value $25K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Prilosec DR 10 mg suspension to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and has a ceiling value of $2,498.94. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is May 3, 2024. The contract did not have a set-aside...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,808.82, is for the supply of Prilosec DR 10 mg suspension medication. The contract has an ultimate completion date of December 12, 2023 and is a firm fixed price delivery order. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award, valued at $12,128.25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,559.32 firm fixed-price delivery order (SPE2DB22D3004|SPE2DB25FPS06) is for the supply of PRILOSEC DR 10 MG SUSPENSION 30S to support military healthcare programs. The contract has an ultimate completion date of February 27, 2025 and was awarded on February 26, 2025. It is not designated as a set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Omeprazole DR 40 mg capsules. The $8,941.98 delivery order is under an existing Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 through November 2026. This IDC allows the DLA to efficiently procure a wide range of...
This federal contract award, valued at $2,154.93, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the delivery of PRILOSEC DR 10 MG SUSPENSION 30S, a pharmaceutical product, to support military healthcare...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,190.94 firm-fixed-price delivery order is for the supply of First-Omeprazole 2 mg/ml suspension, a specialty pharmaceutical product. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., to provide a comprehensive range of...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,368.15 firm fixed-price delivery order contract is for the supply of First-Omeprazole 2 mg/ml suspension, with a period of performance through January 6, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,079.59 firm fixed-price delivery order is for the supply of 4,563,589,873 units of Omeprazole DR 40 mg capsules. The contract has an ultimate completion date of February 8, 2024 and was awarded on February 7, 2024. This order is placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,244.14, is a Firm Fixed Price Delivery Order for the supply of 4,567,089,178 units of Omeprazole DR 20 mg capsules. The contract is not designated under any set-aside program. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB23FRYE3
    Delivery Order

This federal contract award, with ID SPE2DB20D3101|SPE2DB23FRYE3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $25,395.84 firm-fixed-price delivery order is for the supply of Prilosec DR 10 mg suspension in 30-count packages. The contract has an ultimate completion date of September 20, 2023. The award was not designated with a set-aside requirement, indicating open competition.

Amerisourcebergen Drug Corp, as a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC, which runs through November 2026, enables the DLA to efficiently procure essential medications, vaccines, syringes, and other critical medical commodities across various therapeutic areas.

Generated 2/27/25, 9:57 AM